Pegasus Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.47M | Sell |
9,207
-67
| -0.7% | -$67.9K | 2.71% | 13 |
|
|
2025
Q4 | $9.97M | Buy |
9,274
+91
| +1% | +$87K | 3.07% | 12 |
|
|
2025
Q3 | $7.01M | Buy |
9,183
+1,521
| +20% | +$1.13M | 2.25% | 16 |
|
|
2025
Q2 | $5.97M | Buy |
7,662
+2,434
| +47% | +$1.89M | 2.05% | 17 |
|
|
2025
Q1 | $4.32M | Buy |
5,228
+124
| +2% | +$103K | 1.73% | 24 |
|
|
2024
Q4 | $3.94M | Buy |
5,104
+2,256
| +79% | +$1.87M | 1.49% | 23 |
|
|
2024
Q3 | $2.52M | Buy |
2,848
+15
| +0.5% | +$13.5K | 0.96% | 34 |
|
|
2024
Q2 | $2.56M | Buy |
2,833
+3
| +0.1% | +$2.4K | 0.98% | 36 |
|
|
2024
Q1 | $2.2M | Hold |
2,830
| – | – | 0.85% | 40 |
|
|
2023
Q4 | $1.65M | Buy |
2,830
+29
| +1% | +$16.9K | 0.71% | 40 |
|
|
2023
Q3 | $1.5M | Hold |
2,801
| – | – | 0.7% | 42 |
|
|
2023
Q2 | $1.31M | Hold |
2,801
| – | – | 0.58% | 44 |
|
|
2023
Q1 | $962K | Sell |
2,801
-100
| -3% | -$33.7K | 0.48% | 47 |
|
|
2022
Q4 | $1.06M | Sell |
2,901
-95
| -3% | -$33.7K | 0.57% | 44 |
|
|
2022
Q3 | $969K | Buy |
2,996
+100
| +3% | +$31.7K | 0.55% | 48 |
|
|
2022
Q2 | $939K | Hold |
2,896
| – | – | 0.51% | 48 |
|
|
2022
Q1 | $829K | Hold |
2,896
| – | – | 0.36% | 56 |
|
|
2021
Q4 | $800K | Hold |
2,896
| – | – | 0.33% | 62 |
|
|
2021
Q3 | $669K | Hold |
2,896
| – | – | 0.31% | 63 |
|
|
2021
Q2 | $665K | Sell |
2,896
-250
| -8% | -$50.2K | 0.31% | 61 |
|
|
2021
Q1 | $588K | Buy |
3,146
+12
| +0.4% | +$2.35K | 0.3% | 61 |
|
|
2020
Q4 | $529K | Hold |
3,134
| – | – | 0.29% | 61 |
|
|
2020
Q3 | $464K | Hold |
3,134
| – | – | 0.29% | 60 |
|
|
2020
Q2 | $515K | Hold |
3,134
| – | – | 0.35% | 56 |
|
|
2020
Q1 | $435K | Hold |
3,134
| – | – | 0.36% | 56 |
|
|
2019
Q4 | $412K | Hold |
3,134
| – | – | 0.27% | 59 |
|
|
2019
Q3 | $350K | Sell |
3,134
-175
| -5% | -$19.5K | 0.25% | 60 |
|
|
2019
Q2 | $367K | Hold |
3,309
| – | – | 0.28% | 60 |
|
|
2019
Q1 | $429K | Hold |
3,309
| – | – | 0.35% | 57 |
|
|
2018
Q4 | $383K | Hold |
3,309
| – | – | 0.36% | 54 |
|
|
2018
Q3 | $355K | Sell |
3,309
-300
| -8% | -$30K | 0.3% | 58 |
|
|
2018
Q2 | $308K | Hold |
3,609
| – | – | 0.29% | 57 |
|
|
2018
Q1 | $279K | Hold |
3,609
| – | – | 0.27% | 63 |
|
|
2017
Q4 | $305K | Buy |
+3,609
| New | +$307K | 0.3% | 60 |
|
Other funds holding LLY
VCM
VPM
Pegasus Asset Management's LLY Position: Q1 2026 in Review
Pegasus Asset Management reduced its Eli Lilly (LLY) stake by 0.72% in Q1 2026, selling an estimated $67.9K and leaving 9,207 shares worth $8.47M. The position accounts for 2.71% of the portfolio, ranked #13.
Pegasus Asset Management first reported a position in LLY in Q4 2017 and has held it in 34 quarters since. The position peaked at $9.97M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Pegasus Asset Management held 9,207 shares of Eli Lilly worth $8.47M as of Q1 2026.
- Pegasus Asset Management sold 67 Eli Lilly shares in Q1 2026, an estimated $67.9K.
- Eli Lilly made up 2.71% of Pegasus Asset Management's portfolio in Q1 2026, its #13 holding.
- Pegasus Asset Management first reported a position in Eli Lilly in Q4 2017 and has held it in 34 quarters since.
- Pegasus Asset Management's Eli Lilly position peaked at $9.97M in Q4 2025.
- 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Pegasus Asset Management's 13F filing for Q1 2026, filed 21 Apr 2026.